FMC, DE0005785802

FMC stock pre-market at EUR 40.40: plus 0.15 percent

Published on 10/06/2026 at 08:57 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

FMC stock traded pre-market at EUR 40.40 at 8:56 a.m. CEST, up 0.15 percent versus the Lang & Schwarz prior close. Fresenius Medical Care recently outlined changes to its China strategy.

Pflegekraft betreut Patient an Dialysemaschine, schwarz-weiß Reportagestil
Eine eindringliche Schwarzweiß-Reportageaufnahme einer Pflegekraft beim Betreuen eines Patienten an einer Dialysemaschine – ein Motiv, das die menschliche Dimension der Dialyseversorgung wie bei Fresenius Medical Care AG (ISIN DE0005785802) verdeutlicht, Illustration mit AI erstellt.

FMC stock traded pre-market at EUR 40.40 at 8:56 a.m. CEST on October 6, 2026, up 0.15 percent versus the Lang & Schwarz prior close of EUR 40.34 on October 5, 2026.

FMC before the Xetra open

Lang & Schwarz showed a bid of EUR 40.31 and an ask of EUR 40.49. The further course from the Xetra open at 9:00 a.m. CET/CEST is shown by the continuously updated real-time quote of FMC stock.

The previous closing level

The prior close at Lang & Schwarz was EUR 40.34 on October 5, 2026. The current pre-market indication is EUR 0.06 higher than that reference level.

China strategy adjusted

In a September 25, 2026 press release, Fresenius Medical Care said it was refining its China commercial strategy around a more localized portfolio, locally relevant innovation and a focused go-to-market approach. The company said it would discontinue local production and sales of the 4008A hemodialysis system and exit its China peritoneal dialysis business while maintaining existing obligations.

The portfolio actions are expected to result in approximately EUR 110 million of one-time costs, primarily related to impairment charges, scrappage and termination costs. Fresenius Medical Care said the amount is expected to be recognized as a special item in the third quarter of 2026 and that the adjustment is not expected to materially affect the future revenue outlook for its Care Enablement China business.

Disclaimer...

en | DE0005785802 | FMC | boerse | 70239745 | bgmi